Revvity (MEX:PKI) Tariff Resilience Score: 7/10 (As of Jul. 05, 2026)


MEX:PKI Revvity Inc MEX:PKI
75 GF Score
Price MXN1,644.85
GF Value MXN1,742.59
! 11 Warning Signs
View Full Analysis

What is Revvity Tariff Resilience Score?

Revvity MEX:PKI 75 Tariff Resilience Score is 7 as of Jul. 05, 2026. GuruFocus rates MEX:PKI with a GF Score™ of 75/100 and a GF Value™ of MXN1,742.59. The stock has 11 warning signs investors should review. Among 216 Medical Diagnostics & Research companies, Revvity ranks better than 95.83% on this metric.

Revvity has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Revvity has Moderate exposure due to global supply chain and international sales. Some historical impact from tariffs, but diversified markets and alternative suppliers offer mitigation. Industry-specific exemptions reduce vulnerability.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Revvity might have Highly Resilient.

Revvity  (MEX:PKI) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Revvity Tariff Resilience Score Related Terms

MEX:PKI vs ICLR, CRL, MEDP: Tariff Resilience Score Comparison

For the Diagnostics & Research subindustry, Revvity's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Revvity Tariff Resilience Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Revvity's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Revvity's Tariff Resilience Score falls into.


MEX:PKI
75GF Score
Revvity Inc MEX:PKI
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
Revvity (MEX:PKI) has a Tariff Resilience Score of 7 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Revvity ranks #9 out of 216 companies in the Medical Diagnostics & Research industry, placing it in the top 4.2%.
Is Revvity's Tariff Resilience Score too high?
Revvity's current Tariff Resilience Score is 7. Based on the distribution chart, Revvity ranks #9 out of 216 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Revvity has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Revvity's Tariff Resilience Score compare to ICLR and CRL?
According to the Medical Diagnostics & Research industry distribution chart, Revvity ranks #9 out of 216 companies for Tariff Resilience Score. This places Revvity in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Diagnostics & Research company?
A good Tariff Resilience Score depends on the Medical Diagnostics & Research industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Revvity's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revvity stock overvalued right now?
Revvity (MEX:PKI) has a current Tariff Resilience Score of 7. The stock's GF Value™ is MXN1,742.59, compared to a current price of MXN1,644.85 — trading 5.6% below its estimated fair value. The current Tariff Resilience Score is 7. Revvity's overall GF Score™ is 75/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Revvity (MEX:PKI), the current Tariff Resilience Score is 7 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revvity (MEX:PKI) Overvalued in 2026?

Based on GuruFocus' analysis, Revvity stock appears to be undervalued. The current stock price of MXN1,644.85 is trading 5.6% below its estimated GF Value™ of MXN1,742.59.

Key valuation signals for MEX:PKI:

  • Tariff Resilience Score: 7
  • GF Value™: MXN1,742.59 vs. price of MXN1,644.85 (5.6% below fair value)
  • GF Score™: 75/100 with 11 warning signs

No single metric tells the full story. See the MEX:PKI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Revvity Business Description

Address 77 4th Avenue, Waltham, MA, USA, 02451
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
75GF Score

Get the complete analysis for MEX:PKI

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,644.85
Price
MXN1,742.59
GF Value